FindTrial
Sign In

Vascular Protective Effects on Changes of AspiRin in Patients with New Ischemic Stroke While TAking ASpirin (VERITAS)

Vascular Protective Effects on Changes of AspiRin in Patients with New Ischemic Stroke While TAking ASpirin (VERITAS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003931
Enrollment
1172
Registered
2019-05-16
Start date
2014-12-04
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with ischemic stroke admitted within 48 hours of stroke onset, those with non-cardioembolic ischemic stroke, and those with prior use of aspirin before a new ischemic stroke.

Exclusion criteria

Exclusion criteria: Patients who used anticoagulants during admission or at discharge and those who did not use antiplatelet therapy during admission or at discharge.

Design outcomes

Primary

MeasureTime frame
vascuar events: stroke, myocardial infarction, vascular death—

Secondary

MeasureTime frame
composite events: stroke, myocardial infarction, all death;stroke—

Countries

Korea, Republic of

Contacts

Public Contactseung Lee

Seoul National University Bundang Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026